The New Jersey Cannabis Regulatory Commission (CRC) is currently developing and implementing rigorous testing requirements to support the medical and adult-use cannabis industries. These regulations will put New Jersey on par with other states’ quality control measures to ensure that medical patients and adult-use consumers receive accurately labeled and safe products.
US Cannalytics, New Jersey brings the same quality testing and operational experience we deploy in other medical markets to service its first adult-use program. The laboratory received ISO/IEC 17025:2017 accreditation from A2LA in August of 2021 and remains actively licensed by the NJ CRC for both medical and adult-use cannabis products. Our team is thrilled to work with our current multi-state Alternative Treatment Centers (ATCs) and establish new relationships with locally-owned ATCs.
